Immune Thrombocytopenia

• FDA label_change · 2016-10-12
  FDA Approved: PROMACTA — Supplemental Application (Novartis Pharmaceuticals Corporation)

  FDA approved a supplemental application for PROMACTA (eltrombopag olamine) to update its labeling; this action may include changes to indica…